bpc-157 human clinical trial safety trials evidence review regulatory status bpc-157 human trials safety Multifunctionality BPC-157 - Wikipedia

Studies that used 1 mg/day in oral and intravenous trials did not show meaningfully better outcomes than lower doses, and higher doses were associated with more reports of headache, diarrhea, and gastrointestinal effects

A 2022 study in Diabetes, Obesity and Metabolism showed that NNMTi treatment combined with reduced-calorie diet "promoted dramatic whole-body adiposity and weight loss in diet-induced obese mice, rapidly normalizing" weight parameters

These amino acids are intended to support normal cellular signaling and tissue maintenance throughout the body

But it is one of the most talked about peptides in the world of recovery and regenerative health right now and for good reason